Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo

Journal of Investigative Dermatology

Volumn 120, Issue 1, 2003, Pages 56-64

  Yu, Hsin Su ^a   Wu, Chieh Shan ^a   Yu, Chia Li ^b   Kao, Ying Hsien ^a   Chiou, Min Hsi ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Basic fibroblast growth factor; Biostimulation; Melanocyte; Nerve growth factor; Phototherapy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; NERVE GROWTH FACTOR; THYMIDINE;

ADOLESCENT; ADULT; ARTICLE; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; HELIUM NEON LASER; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MALE; MELANOCYTE; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; SKIN PIGMENTATION; TREATMENT OUTCOME; VITILIGO;

EID: 0037243524     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12011.x     Document Type: Article

References (69)

1. Abergel RP, Lyon RF, Castel JC, Dwyer RM, Uitto L: Biostimulation of wound healing by lasers: experimental approaches in animal models and in fibroblast cultures. Dermatol Surg Oncol 13:127-133, 1987
2. 2 failed to accelerate wound healing as assessed by both wound contracture rate and tensile strength. Lasers Surg Med 20:340-345, 1997
3. Babapour R, Glassberg E, Lask GP: Low-energy systems. Clin Dermatol 13:87-90, 1995
4. Basford JR: Low-energy laser therapy: controversies and new research findings. Laser Surg Med 9:1-5, 1989
5. 133 kinase in human melanocytes. Cell Growth Differ 6:291-302, 1995
6. Bradford CS, Sun L, Barnes DW: Basic fibroblast growth factor stimulates proliferation and suppresses melanogenesis in cell cultures derived from early zebrafish embryos. Mol Mar Biol Biotechnol 3:78-86, 1994
7. Cui J, Shen LY Wang GC: Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 97:410-416, 1991
8. Earle V: Clinical treatment guidelines: He-Ne point stimulation energy densities. In: Instruction Manual of OMNIPROBE™ Laser Biostimulation System. Downsview Ontario: Physio Technology Ltd, 1985: p 8
9. Falabella R: Surgical therapies for vitiligo. Clin Dermatol 15:927-939, 1997
10. Fitzpatrick TB: Mechanisms of phototherapy of vitiligo. Arch Dermatol 133:1591-1592, 1997
11. Frohman MA, Dush MK, Martin GR: Rapid production of full length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85:8998-9002, 1988
12. Goldman JA, Casay H, Bass N, et al: Laser therapy of rheumatoid arthritis. Lasers Surg Med 1:93-101, 1980
13. Graeven U, Herlyn M: In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J Immunother 12:199-202, 1992
14. Grimes PE: Psoralen photochemotherapy for vitiligo. Clin Dermatol 15:921-926, 1997
15. Haas AF, Isseroff RR, Wheeland RG, Rood PA, Graves PJ: Low-energy helium-neon laser irradiation increases the motility of cultured human keratinocytes.J Invest Dermatol 94:822-826, 1990
16. Halaban R: The regulation of normal melanocyte proliferation. Pig Cell Res 13:4-14, 2000
17. Halaban R, Longdon R, Birchall N, et al: Basic fibroblast growth factor for human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 107:1611-1619, 1988
18. Halaban R, Fan B, Ann J, Funusaka H, Gitay-Goren H, Neufeld G: Growth factors, receptor kinases and protein tyrosinase phosphatases in normal and malignant melanocytes. J Immunother 12:154-161, 1992a
19. Halaban R, Rubin JS, Funasaka Y, et al: Met and heptocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195-2206, 1992b
20. Hann SK, Lee HJ: Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 35:671-674, 1996
21. Hill CS, Treisman R: Transcripitional regulation by external signals: mechanisms and specificity. Oncogene 7:2195-2206, 1992
22. Hirobe T: Keratinocytes are involved in regulating the developmental changes in the proliferative activity of mouse epidermal melanoblast in serum-free culture. Devel Biol 161:59-69, 1994
23. Horikawa T, Norris DA, Yohn JJ, Zekman T, Travers JB, Morelli JG: Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol 104:256-259, 1995
24. Hu DN, Mccormick SA, Orlow SJ, Rosemblat S, Lin AY, Wo K: Melanogenesis by human uveal melanocytes in vitro. Invest Ophthalmol Vis Sci 36:931-938, 1995
25. Imokawa G, Yada Y, Miyagishi M: Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 267:24675-24680, 1992
26. Jones GE: Establishment, maintenance, and cloning of human primary cell strains. In: Pollard JW Walker JM, eds. Animal Cell Culture. New Jersey: Humana Press, 1990: pp 13-32
27. Kao CH, Ko WC, Ko SS, Tsai RY: A comparative study on autologous graft for segmental vitiligo. Dermatol Sinica 13:65-74, 1995
28. Kemmotsu O, Sato K, Furumido H, et al: Efficacy of low reactive-level laser therapy for pain attenuation of post-herpetic neuralgia. LaserTher 3:71-75, 1991
29. Khullar SM, Bordin P, Barkvoll P, Haanaes HR: Preliminary study of low-level laser for treatment of longstanding sensory alternation in the inferior alveolar nerve. J Oral Maxillofac Surg 54:2-7, 1996
30. Koga M: Vitiligo: a new classification and therapy. Br J Dermatol 97:255-261, 1977
31. Koga M, Tango T: Clinical features and course of type A and type B vitiligo. Br J Dermatol 118:223-228, 1988
32. Kovacs L: The stimulatory effect of laser on the physiological healing process of portio surface. Lasers Surg Med 1:241-252, 1981
33. Kovacs SO: Vitiligo. J Am Acad Dermatol 38:647-666, 1998
34. Lyon RF, Abergel RP, White RA, Dwyer RM, Castel JC, Uitto J: Biostimulation of wound healing in vivo by a helium-neon laser. Ann Plast Surg 18:47-50, 1987
35. Mandel ASH: Skin repigmentation after laser therapy (Russian). Vestn Dermatol Venerol September 9:26-29, 1984
36. Mandel AS, Haberman HF, Pawlowski D, Goldstein E: Non PUVA nonsurgical therapies for vitiligo. Clin Dermatol 15:907-919, 1997
37. Moellmann G, Halaban R: Growth factor receptors and signal transduction regulating the proliferation and differentiation of melanocytes. In: Nordlund JJ, Biossy RE, Hearing VJ, King RA, eds. The Pigmentary System: Physiology and Pathophysiology. New York, NY: Oxford University Press, 1998: pp 135-149
38. Moellmann G, Klein-Angfrer S, Scollay DA, Nordlund JJ, Lerner AB: Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 79:321-330, 1982
39. Moffy AM, Moffy M: Vitiligo: a symptom complex. Int J Dermatol 19:237-244, 1980
40. Morelli JG, Yohn JJ, Lyons MB, Murphy RC, Norris DA: Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Invest Dermatol 93:719-722, 1989
41. Nilsson G, Gorsberg-Nilsson F, Xiang Z, Hallbook F, Nilsson K, Metcalfe DD: Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 27:2295-2301, 1997
42. Norris DA, Horikawa T, Morelli J: Melanocyte destruction and repopulation in vitiligo. Pig Cell Res 7:193-203, 1994
43. Pawson T: Protein modules and signalling networks. Nature 373:573-580, 1995
44. Pincelli C, Yaar M: Nerve growth factor: its significance in cutaneous biology. J Invest Dermatol Symp Proc 2:31-36, 1997
45. Plott RT, Wagner FR: Modern treatment approaches to vitiligo. Cutis 45:311-316, 1990
46. Pötinen PJ: Indications for LLLT and results. In: Pötinen PJ, ed. Low Level Laser Therapy as a Medical Treatment Modality. Tampere: Art Urpo Ltd, 1992a: pp 116-141
47. Pöntinen PJ: Technique of LLLT. In: Pötinen PJ, ed. Low Level Laser Therapy as a Medical Treatment Modality. Tampere; Art Urpo Ltd, 1992b: pp 56-98
48. Pötinen PJ: The physics of laser. In: Pötinen PJ, ed. Low Level Laser Therapy as a Medical Treatment Modality. Tampere: Art Urpo Ltd, 1992c: pp 17-44
49. Rochkind S, Rousso M, Nissan M, Villarreal M, Barr-Nea L, Rees DG: Systemic effects of low-power laser irradiation on the peripheral and central nervous system, cutaneous wounds and burns. Lasers Surg Med 9:174-182, 1989
50. Scherschun L, Kim JJ, Lim HW: Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 44:999-1003, 2001
51. Schwartz F, Brodie C, Appel E, Kazimirsky G, Shainberg A: Effect of helium/neon laser irradiation on nerve growth factor synthesis and secretion in skeletal muscle cultures. J Photochem Photobiol B Biol 66:195-200, 2002
52. Scudiero DA, Shoemaker RH, Paull KD, et al: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833, 1988
53. Staricco RG: Mechanism of migration of the melanocytes from hair follicle into the epidermis following dermabrasion. J Invest Dermatol 36:99-104, 1961
54. Staricco RG, Miller-Milinska A: Activation of the amelanotic melanocytes in the outer root sheath of hair follicle following ultraviolet rays exposure. J Invest Dermatol 39:163, 1962
55. Staricco RG: Activation of melanotic melanocytes in the outer root sheath of hair follicle following ultraviolet exposure. J Invest Dermatol 36:163-164, 1994
56. Toyoda M, Luo Y, Makino T, Matsui C, Morohashi M: Calcitonin gene-related peptide upregulates melanogenesis and enhances melanocyte dendricity via induction of keratinocyte-derived melanotrophic factors. J Invest Dermatol Symp Proc 4:116-125, 1999
57. Tripathi RC, Li JP, Chalam KV, Tripathi BJ: Expression of growth factor mRNAs by human tendon's capsule fibroblasts. Exp Eye Res 63:339-346, 1996
58. Walsh LJ: The current status of low level laser therapy in dentistry. Part 1. Soft tissue applications. Aust Dent J 42:247-255, 1997
59. Westerhof W, Nieuweboer-Krobotova L: Treatment of vitiligo with UVB radiation vs topical psoralen plus UVA. Arch Dermatol 133:1525-1528, 1997
60. Wu CS, Yu HS, Chang HR, Yu CL, Wu BN: Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions. J Dermatol Sci 23:53-62, 2000
61. Yaar M, Grossman K, Eller M, Gilchrest BA: Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biol 115:821-828, 1991
62. Yaksich I, Tan LC, Previn V: Low energy laser for treatment of post-herpetic neuralgia. Ann Acad Med Singapore 22(3 Suppl.):441-442, 1993
63. Yohn JJ, Morelli JG, Walchak SJ, Rundel KB, Norris DA, Zamora MR: Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol 100:23-26, 1993
64. Young S, Bolton P, Dyson M, Harvey W, Diamantopoulos C: Macrophage responsiveness to light therapy. Lasers Surg Med 9:497-505, 1989
65. Yu HS: Treatment of vitiligo vulgaris with helium-neon laser. MB Derma 35:13-18, 2000
66. Yu HS, Kao CH, Yu CL: Coexistence and relationship of antikeratinocyte and anti-melanocyte antibodies in patients with nonsegmental-type vitiligo. J Invest Dermatol 100:823-828, 1993
67. Yu W, Naim JO, Lanzafame RJ: The effect of laser irradiation on the release of bFGF from 3T3 fibroblast. Photochem Photobiol 59:167-170, 1994
68. Yu HS, Chang KL, Yu CL, Chen JW, Chen GS: Low-energy helium-neon laser irradiation stimulates interleukin-1a and interkeukin-8 release from cultured human keratinocytes. J Invest Dermatol 107:593-596, 1996
69. Zhai S, Yaar M, Doyle M, Gilchrest BA: Nerve growth factor rescues pigment cells from ultraviolet induced apoptosis by upregulating BCL-2 levels. Exp Cell Res 224:335-343, 1996